LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
0.31623
 47.93 27.76 2014 4421 0.4555 0.7962
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 47.93 27.76 2365 4421 0.5349 0.8361
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 47.93 27.76 2411 4421 0.5453 0.8409
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 49.63 27.76 1725 4818 0.3580 0.7421
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 49.63 27.76 1762 4818 0.3657 0.7471
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 49.63 27.76 2072 4818 0.4301 0.7855
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 49.63 27.76 2106 4818 0.4371 0.7894
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 49.63 27.76 2465 4818 0.5116 0.8277
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 49.63 27.76 2504 4818 0.5197 0.8316
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 51.33 27.76 1817 5117 0.3551 0.7429
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 51.33 27.76 1856 5117 0.3627 0.7479
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 51.33 27.76 2163 5117 0.4227 0.7838
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 51.33 27.76 2205 5117 0.4309 0.7884
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 51.33 27.76 2578 5117 0.5038 0.8259
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 51.33 27.76 2616 5117 0.5112 0.8294
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 53.04 27.76 1889 5365 0.3521 0.7431
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 53.04 27.76 1916 5365 0.3571 0.7464
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 53.04 27.76 2229 5365 0.4154 0.7815
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 53.04 27.76 2272 5365 0.4234 0.7860
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 53.04 27.76 2655 5365 0.4948 0.8230
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 53.04 27.76 2700 5365 0.5032 0.8271
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 54.74 27.76 1948 5606 0.3475 0.7421
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 54.74 27.76 1978 5606 0.3528 0.7456
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 54.74 27.76 2345 5606 0.4183 0.7848
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 54.74 27.76 2385 5606 0.4254 0.7888
MN20160318_Q01
H12